Marylee’s son, father, and two cousins have BCM. Like most affected families, the correct diagnosis wasn’t made until 2017 when her son was diagnosed by genetic testing.
Marylee is an alum of UNC-Chapel Hill and Jefferson Medical College and competed residency at Baylor College of Medicine. After four years in private practice as a dual-boarded internist and pediatrician, she now works at a private equity firm in New York City.
Her goal is to raise awareness and find more funds to achieve gene therapy for BCM.